Cargando…
P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428860/ http://dx.doi.org/10.1097/01.HS9.0000969452.06532.fc |
| _version_ | 1785090571655708672 |
|---|---|
| author | Burger, Jan Kim, Ekaterina Sivina, Mariela Issa, Ghayas Thompson, Philip G. Wierda, William Ferrajoli, Alessandra |
| author_facet | Burger, Jan Kim, Ekaterina Sivina, Mariela Issa, Ghayas Thompson, Philip G. Wierda, William Ferrajoli, Alessandra |
| author_sort | Burger, Jan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428860 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288602023-08-17 P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL Burger, Jan Kim, Ekaterina Sivina, Mariela Issa, Ghayas Thompson, Philip G. Wierda, William Ferrajoli, Alessandra Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428860/ http://dx.doi.org/10.1097/01.HS9.0000969452.06532.fc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Burger, Jan Kim, Ekaterina Sivina, Mariela Issa, Ghayas Thompson, Philip G. Wierda, William Ferrajoli, Alessandra P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title | P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title_full | P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title_fullStr | P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title_full_unstemmed | P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title_short | P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL |
| title_sort | p637: time-limited treatment with acalabrutinib plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia patients: early results of an ongoing phase 2 trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428860/ http://dx.doi.org/10.1097/01.HS9.0000969452.06532.fc |
| work_keys_str_mv | AT burgerjan p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT kimekaterina p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT sivinamariela p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT issaghayas p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT thompsonphilip p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT gwierdawilliam p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial AT ferrajolialessandra p637timelimitedtreatmentwithacalabrutinibplusobinutuzumabintreatmentnaivechroniclymphocyticleukemiapatientsearlyresultsofanongoingphase2trial |